Health in Tech Inc., a Nevada-based corporation, has announced new compensation terms for its top executives in connection with the development of two new programs, "Program 1" and "Program 2." The Compensation Committee of the Board of Directors approved restricted stock awards (RSAs) for CEO Tim Johnson, CFO Linlin (Julia) Qian, and CTO (Mo) Imran Yousuf on August 15, 2025. Mr. Johnson will receive 34,000 shares of restricted stock, split equally between the two programs. Ms. Qian will receive a total of 27,000 shares, with 10,000 shares for Program 1 and 17,000 shares for Program 2. Mr. Yousuf is set to receive 7,000 shares, with an equal split between the two programs. The vesting of these shares is contingent upon the successful launch and full operational status of the programs in the marketplace, with a structured vesting schedule for each program. The RSAs were issued under the company's Equity Incentive Plan.